Abhinava K Mishra

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Papillary Thyroid

Top Venues

International journal of environmental research and public health

Biotech (Basel (Switzerland))

This page only lists publications with an associated author ORCID identifier.

Publications

Abhinava K Mishra, Ashna Gupta, Gunjan Dagar, Dayasagar Das, Abhishek Shankar, Shabirul Haque, Chandra Prakash Prasad, Archana Singh, Ajaz Ahmad Bhat, Muzafar A Macha, Moez Benali, Kamal S Saini, Rebecca Ann Previs, Deepak Saini, Dwaipayan Saha, Preyangsee Dutta, Aseem Rai Bhatnagar, Mrinalini Darswal, Abhishek Shankar, Mayank Singh
CAR-T-Cell Therapy in Multiple Myeloma: B-Cell Maturation Antigen (BCMA) and Beyond. Vaccines 11 (11) (2023)
Shruti Sharma, Yogesh Kumar Gupta, Abhinava K Mishra
Analysis and Prediction of COVID-19 Multivariate Data Using Deep Ensemble Learning Methods. International journal of environmental research and public health 20 (11) (2023)
Neha Varshney, Abhinava K Mishra
Deep Learning in Phosphoproteomics: Methods and Application in Cancer Drug Discovery. Proteomes 11 (2) (2023)
Gamze Gulden, Berranur Sert, Tarik Teymur, Yasin Ay, Nulifer Neslihan Tiryaki, Abhinava K Mishra, Ercument Ovali, Nevzat Tarhan, Cihan TaŞtan
CAR-T Cells with Phytohemagglutinin (PHA) Provide Anti-Cancer Capacity with Better Proliferation, Rejuvenated Effector Memory, and Reduced Exhausted T Cell Frequencies. Vaccines 11 (2) (2023)
Gamze Gulden, Berranur Sert, Tarik Teymur, Yasin Ay, Nulifer Neslihan Tiryaki, Abhinava K Mishra, Ercument Ovali, Nevzat Tarhan, Cihan TaŞtan
CAR-T Cells with Phytohemagglutinin (PHA) Provide Anti-Cancer Capacity with Better Proliferation, Rejuvenated Effector Memory, and Reduced Exhausted T Cell Frequencies. Vaccines 11 (2) (2023)
Ashutosh Pandey, Abhinava K Mishra
Immunomodulation, Toxicity, and Therapeutic Potential of Nanoparticles. Biotech (Basel (Switzerland)) 11 (3) (2022)